Samuele Cortese

Active 2005–2026

255
Papers
26,035
Citations
87
h-index
234
i10-index

Citations

Citations per year for Samuele Cortese1995: 1 citations2006: 1 citations2007: 12 citations2008: 27 citations2009: 43 citations2010: 30 citations2011: 63 citations2012: 62 citations2013: 86 citations2014: 179 citations2015: 119 citations2016: 133 citations2017: 155 citations2018: 126 citations2019: 546 citations2020: 629 citations2021: 736 citations2022: 707 citations2023: 821 citations2024: 1,553 citations2025: 857 citations2026: 52 citations1996–2005: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,722 citing papers, 18.9% of this breakdownUnited Kingdom: 929 citing papers, 10.2% of this breakdownGermany: 557 citing papers, 6.1% of this breakdownChina: 554 citing papers, 6.1% of this breakdownItaly: 497 citing papers, 5.4% of this breakdownCanada: 407 citing papers, 4.5% of this breakdownNetherlands: 383 citing papers, 4.2% of this breakdownAustralia: 361 citing papers, 4% of this breakdownSpain: 328 citing papers, 3.6% of this breakdownSweden: 288 citing papers, 3.1% of this breakdownFrance: 255 citing papers, 2.8% of this breakdownSwitzerland: 209 citing papers, 2.3% of this breakdown
0%18.9%Other 28.8%

Fields

  • Medicine59.9%
  • Neuroscience19.5%
  • Psychology12.6%
  • Biochemistry, Genetics and Molecular Biology3.1%
  • Health Professions1%
  • Social Sciences0.9%
  • Other3%

Topics

  • Attention Deficit Hyperactivity Disorder17.3%
  • Functional Brain Connectivity Studies5.4%
  • Autism Spectrum Disorder Research5%
  • Neural and Behavioral Psychology Studies4.1%
  • Sleep and related disorders3.1%
  • Child and Adolescent Psychosocial and Emotional Development2.5%
  • Other62.6%

Coauthors

All papers

Open in search
  1. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Haavik, Catharina A. Hartman, Cynthia M. Hartung, Stephen P. Hinshaw, Pieter J. Hoekstra, Chris Hollis, Scott H. Kollins, J. J. Sandra Kooij, Jonna Kuntsi, Henrik Larsson, Tingyu Li, Jing Liu, Eugene Merzon, Gregory W. Mattingly, Paulo Mattos, Suzanne McCarthy, Amori Yee Mikami, Brooke S. G. Molina, Joel T. Nigg, Diane Purper‐Ouakil, Olayinka Omigbodun, Guilherme V. Polanczyk, Yehuda Pollak, Alison Poulton, Ravi Philip Rajkumar, Andrew Reding, Andreas Reif, Katya Rubia, Julia J. Rucklidge, Marcel Romanos, Josep Antoni Ramos‐Quiroga, Arnt Schellekens, Anouk Scheres, Renata Schoeman, Julie B. Schweitzer, Henal Shah, Mary V. Solanto, Edmund Sonuga‐Barke, César A. Soutullo, Hans-Christoph Steinhausen, James M. Swanson, Anita Thapar, Gail Tripp, Geurt van de Glind, Wim van den Brink, Saskia Van der Oord, André Venter, Benedetto Vitiello, Susanne Walitza, Yufeng Wang - Neuroscience & Biobehavioral Reviews 2021 cited by 1,392

  2. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2018 cited by 1,333

  3. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019

    Authors: , , , , , , , , , , , , , , - Molecular Psychiatry 2023 cited by 510

  4. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jae Il Shin, Elena Dragioti - BMJ 2023 cited by 245

  5. Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials

    Authors: , , , , , , , , , , - Molecular Psychiatry 2022 cited by 251

  6. Toward Systems Neuroscience of ADHD: A Meta-Analysis of 55 fMRI Studies

    Authors: , , , , , , - American Journal of Psychiatry 2012 cited by 1,063

  7. Attention-deficit/hyperactivity disorder

    Authors: , , , , , , , , , , , - Nature Reviews Disease Primers 2024 cited by 277

  8. Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2022 cited by 211

  9. Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas

    Authors: , , , , , , , , , , , , , - World Psychiatry 2021 cited by 311

  10. Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2023 cited by 180

  11. Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - World Psychiatry 2023 cited by 140

  12. Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction

    Authors: , , , , , , , , , , , , , , , , , , , , - World Psychiatry 2023 cited by 117

  13. The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents

    Authors: , , , , , , , , , - World Psychiatry 2023 cited by 107

  14. Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments

    Authors: , , , , , , , , , , , , , , , , , , , , , - American Journal of Psychiatry 2013 cited by 1,172

  15. Systematic Review and Meta-analysis: Resting-State Functional Magnetic Resonance Imaging Studies of Attention-Deficit/Hyperactivity Disorder

    Authors: , , , , - Journal of the American Academy of Child & Adolescent Psychiatry 2020 cited by 171

  16. Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder

    Authors: - New England Journal of Medicine 2020 cited by 324

  17. Brain alterations in children/adolescents with ADHD revisited: A neuroimaging meta-analysis of 96 structural and functional studies

    Authors: , , , , , , , - Neuroscience & Biobehavioral Reviews 2019 cited by 255

  18. Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review

    Authors: , , , , , , , , , , , , , , , - Neuroscience & Biobehavioral Reviews 2022 cited by 107

  19. Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis

    Authors: , , , , , - American Journal of Psychiatry 2015 cited by 587

  20. Disparities in Screening and Treatment of Cardiovascular Diseases in Patients With Mental Disorders Across the World: Systematic Review and Meta-Analysis of 47 Observational Studies

    Authors: , , , , , , , , , , , , , , , , , , , , - American Journal of Psychiatry 2021 cited by 137

  21. ADHD Pharmacotherapy and Mortality in Individuals With ADHD

    Authors: , , , , , , , , , - JAMA 2024 cited by 111

  22. Association between anxiety and hypertension in adults: A systematic review and meta-analysis

    Authors: , , - Neuroscience & Biobehavioral Reviews 2021 cited by 131

  23. Sleep in Children With Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Subjective and Objective Studies

    Authors: , , , - Journal of the American Academy of Child & Adolescent Psychiatry 2009 cited by 643

  24. Cognitive Training for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials

    Authors: , , , , , , , , , , , - Journal of the American Academy of Child & Adolescent Psychiatry 2014 cited by 627